The Efficacy of an AI-Based Rehabilitation Treatment in Patients With Anxiety Disorders
Key facts
- Who runs it
- Shanghai Mental Health Center
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 158 people, planned
- Started
- 25 Apr 2026
- Expected to end
- 25 Dec 2026
- Type of study
- Interventional, 2 groups
- Treatments tested
- AI-based rehabilitation treatment combined with standard treatment
- Treatment as Usual (TAU)
- Record updated
- 22 April 2026
Who can take part
- Age
- 18 years to 60 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 3 criteriaShow less
Other criteria
- Subjects with anxiety disorders
- Inclusion Criteria:; In accordance with ICD-11 for Anxiety Disorders; Between the ages of 18-60; Completed at least 9 years of education; Ability to use computers or smartphone; Native Chinese speaker; Signing informed consent
- Exclusion Criteria:; With severe psychiatric symptoms requiring hospitalization, or unable to complete the required assessment and treatment; Use of cognitive-enhancing medications within the past 6 months; With intellectual, visual, or auditory impairments that affect their ability to interact with aided-diagnostic systems
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 60 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The trail aimed to test the efficacy of AI-based rehabilitation treatment in patients with anxiety disorders. Specifically, the objective of this trial is to determine whether the AI-based rehabilitation combined with treatment as usual is more effective than treatment as usual alone in improving outcomes in patients with anxiety disorders.
The 2 groups in the trial
- AI-based rehabilitation treatment combined with standard treatmentTreatment being tested
Both groups will receive treatment as usual(TAU) provided by the clinical team, including medication, exercise and psychological education. Rehabilitation treatment will be delivered to participants in the testing group through an AI-based intervention system.
Treatment: AI-based rehabilitation treatment combined with standard treatment and Treatment as Usual (TAU)
- Treatment as usualOther group
Participants in the treatment-as-usual group were offered standard treatment at the mental health hospitals as determined by the clinical team.
Treatment: Treatment as Usual (TAU)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Randomized Controlled Trial Protocol Testing the Efficacy of an AI-Based Rehabilitation Treatment in Patients With Anxiety Disorders
- Fit questions
- Built from NCT07545070, who can take part
- Record updated
- 22 April 2026